Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9

Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9

The capacity of certain adeno-associated virus (AAV) vectors to cross the blood–brain barrier after intravenous delivery offers a unique opportunity for noninvasive brain delivery. However, without a well-tailored system, the use of a peripheral route injection may lead to undesirable transgene expr...

Full description

Bibliographic Details
Main Authors:	Jonathan Dashkoff, Eli P Lerner, Nhi Truong, Jacob A Klickstein, Zhanyun Fan, Dakai Mu, Casey A Maguire, Bradley T Hyman, Eloise Hudry
Format:	Article
Language:	English
Published:	Elsevier 2016-01-01
Series:	Molecular Therapy: Methods & Clinical Development
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050117300396

Similar Items

Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65
by: Eloise Hudry, et al.
Published: (2018-09-01)

Selection of an Efficient AAV Vector for Robust CNS Transgene Expression
by: Killian S. Hanlon, et al.
Published: (2019-12-01)

AAV Targeting of Glial Cell Types in the Central and Peripheral Nervous System and Relevance to Human Gene Therapy
by: Simon J. O’Carroll, et al.
Published: (2021-01-01)

Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats.
by: Hongwei Yu, et al.
Published: (2013-01-01)

Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease
by: Piotr Hadaczek, et al.
Published: (2016-01-01)

Correction: Intraganglionic AAV6 Results in Efficient and Long-Term Gene Transfer to Peripheral Sensory Nervous System in Adult Rats.
Published: (2015-01-01)

Adenovirus-mediated delivery of transgenes to both the central nervous system and peripheral targets : potential and problems
by: Hornsey, Mark Alan
Published: (2001)

Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1
by: Shilpa Prabhakar, et al.
Published: (2019-12-01)

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9
by: Asad Jan, et al.
Published: (2019-11-01)

Recent progress and considerations for AAV gene therapies targeting the central nervous system
by: Erik Allen Lykken, et al.
Published: (2018-05-01)

RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.
by: Christian T Farrar, et al.
Published: (2014-01-01)

IL12-mediated liver inflammation reduces the formation of AAV transcriptionally active forms but has no effect over preexisting AAV transgene expression.
by: Irene Gil-Fariña, et al.
Published: (2013-01-01)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
by: Jérôme Denard, et al.
Published: (2018-09-01)

Cerebral Organoids: A Human Model for AAV Capsid Selection and Therapeutic Transgene Efficacy in the Brain
by: Josse A. Depla, et al.
Published: (2020-09-01)

Intramuscular injection of AAV8 in mice and macaques is associated with substantial hepatic targeting and transgene expression.
by: Jenny A Greig, et al.
Published: (2014-01-01)

Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa
by: Cia-Hin Lau, et al.
Published: (2019-06-01)

Evaluation of lateral spread of transgene expression following subretinal AAV-mediated gene delivery in dogs.
by: Ashlee R Bruewer, et al.
Published: (2013-01-01)

TAILOR: transgene activation and inactivation using lox and rox in zebrafish.
by: Joon Tae Park, et al.
Published: (2013-01-01)

Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates
by: Benjamin J. Samelson-Jones, et al.
Published: (2020-06-01)

Recombinant human myelin-associated glycoprotein promoter drives selective AAV-mediated transgene expression in oligodendrocytes
by: Georg evon Jonquieres, et al.
Published: (2016-02-01)

Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening
by: Angelika Alonso, et al.
Published: (2013-01-01)

Inhibition of HBV Expression in HBV Transgenic Mice Using AAV-Delivered CRISPR-SaCas9
by: Hao Li, et al.
Published: (2018-09-01)

AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
by: Vinicius Toledo Ribas, et al.
Published: (2021-02-01)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
by: Hildegund C. J. Ertl
Published: (2021-04-01)

Overcoming Toxicity from Transgene Overexpression Through Vector Design in AAV Gene Therapy for GM2 Gangliosidoses
by: Golebiowski, Diane L.
Published: (2016)

Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
by: Nikisha Carty, et al.
Published: (2013-01-01)

AAV8 Gene Therapy for Crigler-Najjar Syndrome in Macaques Elicited Transgene T Cell Responses That Are Resident to the Liver
by: Jenny A. Greig, et al.
Published: (2018-12-01)

AAV9-mediated central nervous system–targeted gene delivery via cisterna magna route in mice
by: Vera Lukashchuk, et al.
Published: (2016-01-01)

Widespread gene transfer in the central nervous system of cynomolgus macaques following delivery of AAV9 into the cisterna magna
by: Christian Hinderer, et al.
Published: (2014-01-01)

Expression of metalloproteinases in the peripheral nervous system
by: Platt, Christopher Ian
Published: (2004)

Regeneration in the aging peripheral nervous system
by: Painter, Michio Wendell
Published: (2014)

Peripheral nervous system control for neuroprostheses
by: Buil, Jeroen
Published: (2017)

On the structural relations of the peripheral nervous system
by: Coghill, John
Published: (1857)

Peripheral Nervous System-Machine Interfaces
Published: (2018)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
by: Qizhao Wang, et al.
Published: (2017-03-01)

Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.
by: Gabriella Cotugno, et al.
Published: (2012-01-01)

Systemic AArh10 provides higher transgene expression than AAV9, in the brain and the spinal cord of neonatal mice
by: Yannick eTanguy, et al.
Published: (2015-07-01)

Development of AAV-mediated RNAi therapy for chronic hepatitis B infection in transgenic and human liver chimeric mice models
by: Cheng-Pu Sun, et al.
Published: (2013)

AAV8 locoregional delivery induces long-term expression of an immunogenic transgene in macaques despite persisting local inflammation
by: Gwladys Gernoux, et al.
Published: (2021-03-01)

AAV-Mediated Gene Delivery in a Feline Model of Sandhoff Disease Corrects Lysosomal Storage in the Central Nervous System
by: Hannah E. Rockwell, et al.
Published: (2015-04-01)